Alpha 2.0
Login Register
» Articles » PMID: 4148416

Susceptibility of Recently Isolated Pathogenic Bacteria to Trimethoprim and Sulfamethoxazole Separately and Combined

Overview
Journal J Infect Dis
Publisher Oxford University Press
Specialty Infectious Diseases
Date 1973 Nov 1
PMID 4148416
Citations 9
Authors
M C Bach
M FINLAND
O GOLD
C Wilcox
Affiliations
Soon will be listed here.
Citing Articles

The antibacterial activities of aditoprim and its efficacy in the treatment of swine streptococcosis.

Cheng G, Xu Y, Zhu X, Xie S, Wang L, Huang L Sci Rep. 2017; 7:41370.

PMID: 28145487 PMC: 5286432. DOI: 10.1038/srep41370.

Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Brogden R, Carmine A, Heel R, Speight T, Avery G Drugs. 1982; 23(6):405-30.

PMID: 7049657 DOI: 10.2165/00003495-198223060-00001.

In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes.

Winslow D, Pankey G Antimicrob Agents Chemother. 1982; 22(1):51-4.

PMID: 6812496 PMC: 183673. DOI: 10.1128/AAC.22.1.51.

In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole.

Kirven L, Thornsberry C Antimicrob Agents Chemother. 1974; 6(6):869-70.

PMID: 4548834 PMC: 444752. DOI: 10.1128/AAC.6.6.869.

Sensitivity of different Pseudomonas species and Aeromonas hydrophila to trimethoprim and sulfamethoxazole separately and in combination.

Nord C, Wadstrom T, Wretlind B Med Microbiol Immunol. 1974; 160(1):1-7.

PMID: 4214032 DOI: 10.1007/BF02124338.